News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
AstraZeneca PLC Fails to Win FDA Approval for Axanum
June 1, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- AstraZeneca Plc, the U.K.’s second- largest drugmaker, failed to get approval from U.S. regulators for an experimental treatment to prevent ulcers.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
AstraZeneca Pharmaceuticals LP
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Approvals
Milestone’s Long Regulatory Road Ends in Approval for Cardamyst
December 15, 2025
·
2 min read
·
Tristan Manalac
COVID-19
Prasad’s Claim of 10 Pediatric Deaths From COVID-19 Shots Overblown: Report
December 15, 2025
·
2 min read
·
Tristan Manalac
Vaccines
FDA Plans Black Box Warning for COVID-19 Vaccines: Report
December 12, 2025
·
3 min read
·
Heather McKenzie
FDA
Opinion: FDA Is Built on Predictability and Expertise, Not Norm-Breaking
December 11, 2025
·
5 min read
·
Steven Grossman
